Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Experimental Dementia Research

Group photo of the Experimental Dementia Research group.

Dementia defines a category of diseases characterized by progressive and debilitating decline in cognitive functions. The major causes of dementia are neurodegenerative diseases of aging, including Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia. In addition, vascular disease is an important cause and contributor. Dementia is a major and growing public health concern as the number of patients and the associated health care costs continue to rise. Alzheimer’s disease is the leading cause of dementia. Currently, there are no treatments known to halt or slow down the progression of this disease in afflicted individuals. In the Experimental Dementia Research Unit we work to uncover the cell biological and pathological basis of dementia, with a focus on Alzheimer’s disease. We provided the first evidence that age-related protein aggregation in Alzheimer’s disease initiates with aberrant accumulation and aggregation of β-amyloid peptides within vulnerable neurons, in particular their terminals. The goal of our research is to provide biological and therapeutic insights that will help in the development of more effective new therapies for dementia.

Contact

Professor Gunnar Keppler Gouras

E-mail: gunnar [dot] gouras [at] med [dot] lu [dot] se
Tel: +46 46 222 03 09

 

edr_pic